The Californer - IAM and Universiti Malaya form collaborative relationship/ MOU

Trending...

The Institute of Adherence to Medication proudly announces a groundbreaking collaboration with Universiti Malaya to spearhead the utilization of the Morisky Medication Adherence Scale (MMAS) in clinical research studies worldwide.

SIGNAL HILL, Calif. - Californer -- Institute of Adherence to Medication and Universiti Malaya Unite to Pioneer Morisky Medication Adherence Scale in Global Clinical Research Studies

[Signal Hill, California] - The Institute of Adherence to Medication proudly announces a groundbreaking collaboration with Universiti Malaya to spearhead the utilization of the Morisky Medication Adherence Scale (MMAS) in clinical research studies Worldwide.

As a pivotal initiative in healthcare, the Institute of Adherence to Medication has been at the forefront of advancing medication adherence strategies. The collaboration with Universiti Malaya, a prestigious institution renowned for healthcare innovation, signifies a significant step towards integrating the MMAS into clinical research studies conducted by students and researchers globally.

"Our partnership with Universiti Malaya reflects our joint commitment to revolutionizing clinical research and enhancing patient care through robust medication adherence assessment tools," expressed Philip Morisky, Founder at the Institute of Adherence to Medication.

More on The Californer

The Morisky Medication Adherence Scale (MMAS) serves as a validated and widely acclaimed tool for assessing medication adherence levels among patients across diverse healthcare settings. This collaboration aims to empower students and researchers worldwide with access to this essential scale, fostering a deeper understanding of adherence behaviors and promoting evidence-based interventions to improve patient outcomes.

"We believe that by integrating the MMAS, a user-friendly and highly accurate tool, into our clinical research studies, we can catalyze innovative approaches to address medication adherence challenges, ultimately benefiting patients globally," emphasized Baharudin Ibrahim.

Through this collaboration, the Institute of Adherence to Medication and Universiti Malaya aim to not only facilitate access to the MMAS but also provide guidance and resources for its effective implementation in clinical research. This initiative is poised to elevate the quality of healthcare research, enabling the next generation of healthcare professionals to make meaningful contributions to patient-centered care practices.

About the Institute of Adherence to Medication:

The Institute of Adherence to Medication (IAM) is a globally recognized organization dedicated to advancing the research, education, and training related to medication adherence. IAM specializes in providing access to our validated psychometric assessment instruments, specifically the MMAS-4© and MMAS-8©, which serve as primary and secondary outcome measures in clinical trials and are pivotal in ensuring the continuity of care and patient self-management. IAM's pioneering efforts have expanded the reach of these instruments across numerous universities, healthcare institutions, and healthcare settings worldwide, contributing significantly to improved patient outcomes and healthcare quality.

More on The Californer

About Universiti Malaya School of Pharmacy:

The School of Pharmacy at Universiti Malaya stands as a leading academic institution renowned for its excellence in pharmaceutical education, research, and innovation. Comprising dedicated faculty and researchers, the department focuses on cutting-edge reseaRCH to advance pharmaceutiCal Sciences, Patient Care, and Community Health. With state-of-the-art facilities and a commitment to excellence, the department plays a pivotal role in shaping future pharmacists and contributing significantly to the advancement of healthcare solutions. Their collaborative approach with institutions like the Institute of Adherence to Medication showcases their dedication to pioneering initiatives that transcend academic boundaries, ultimately benefitting global healthcare standards.

For media inquiries or further information, please contact:

[Philip Morisky, MBA
Institute of Adherence to Medication
philip.morisky@adherence.cc]